(Q48292762)

10 February 2018

title

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain (English)

1 reference

10 February 2018

1 reference

2

1 reference

10 February 2018

author name string

A Bortolozzi

1

1 reference

10 February 2018

M Toth

3

1 reference

10 February 2018

P Celada

4

1 reference

10 February 2018

F Artigas

5

1 reference

10 February 2018

publication date

30 January 2007

1 reference

10 February 2018

published in

Psychopharmacology

1 reference

10 February 2018

volume

191

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

745-758

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-007-0698-y

exact match

0 references

cites work

Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0698-Y

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0698-Y

The frontal lobes and schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0698-Y

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase

21 January 2018

1 reference

12 December 2020

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

12 December 2020

In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice

1 reference

12 December 2020

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties

1 reference

12 December 2020

Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors

1 reference

12 December 2020

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

1 reference

12 December 2020

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

1 reference

12 December 2020

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

1 reference

12 December 2020

Partial agonists, full agonists, antagonists: dilemmas of definition

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus

1 reference

12 December 2020

Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus

1 reference

12 December 2020

Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain

1 reference

12 December 2020

Increased anxiety of mice lacking the serotonin1A receptor

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

12 December 2020

Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

1 reference

12 December 2020

Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

1 reference

12 December 2020

Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems

1 reference

12 December 2020

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus

1 reference

12 December 2020

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

1 reference

12 December 2020

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

12 December 2020

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

1 reference

12 December 2020

Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study

1 reference

12 December 2020

The control of firing pattern in nigral dopamine neurons: burst firing

1 reference

12 December 2020

In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

1 reference

12 December 2020

Focus on aripiprazole

1 reference

12 December 2020

Cognitive impairment in schizophrenia is the core of the disorder.

1 reference

12 December 2020

Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase

1 reference

12 December 2020

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

12 December 2020

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

12 December 2020

Mechanism of new antipsychotic medications: occupancy is not just antagonism

1 reference

12 December 2020

Catching up on schizophrenia: natural history and neurobiology

1 reference

12 December 2020

Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists

1 reference

12 December 2020

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

12 December 2020

Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats

1 reference

12 December 2020

Partial dopamine agonists in the treatment of psychosis

1 reference

12 December 2020

Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

12 December 2020

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

1 reference

12 December 2020

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

12 December 2020

Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

1 reference

12 December 2020

Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain

1 reference

12 December 2020

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

1 reference

12 December 2020

Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist.

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas

1 reference

12 December 2020

A G protein couples serotonin and GABAB receptors to the same channels in hippocampus

1 reference

12 December 2020

Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

12 December 2020

Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex

1 reference

12 December 2020

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

12 December 2020

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

1 reference

12 December 2020

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its a

1 reference

12 December 2020

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

1 reference

12 December 2020

Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature

1 reference

12 December 2020

Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex

1 reference

12 December 2020

Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens

1 reference

12 December 2020

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

1 reference

12 December 2020

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

12 December 2020

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

1 reference

12 December 2020

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

1 reference

12 December 2020

GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata

1 reference

12 December 2020

Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

1 reference

12 December 2020

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

12 December 2020

Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex

1 reference

12 December 2020

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

12 December 2020

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

1 reference

12 December 2020

Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic

1 reference

12 December 2020

Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.

1 reference

12 December 2020

10.1007/S00213-007-0698-Y

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018